Article | August 22, 2022

How To Reduce Operational Costs Of Clinical Trials In Uncertain Economic Conditions

By Blake Adams, Florence

GettyImages-1199010148-cost-analysis-financial-reporting-finance-graph

Clinical trials can’t avoid fluctuating economic conditions. Changes in the market can especially impact emerging and early-stage biotech companies with limited cash reserves. A clinical trial’s fate can hang in the balance when funding conditions change, especially in early phases.

In an informal survey of 43 CROs in June 2022, Florence found that:

  • 57% of sponsors and CROs say the 2022 economic downturn is impacting their operations
  • 70% of sponsors and CROs say their budgets have been reduced or they expect them to be reduced

Numerous factors affect the cost of a clinical trial, but one of the largest expenses is site and study management. Sending an army of CRAs to dispersed research sites quickly adds up. Additionally, limited visibility into site operations leads to wasted resources, costly delays, and even missed trial milestones. 

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader